NCT04162509 (GARET2019) is a NA clinical trial of AR app in Fear of Spiders, sponsored by Prof. Dominique de Quervain, MD.

Who is sponsoring NCT04162509?

NCT04162509 is sponsored by Prof. Dominique de Quervain, MD.

What drugs are being tested in NCT04162509?

Interventions in NCT04162509: AR app.

What condition does NCT04162509 study?

NCT04162509 studies Fear of Spiders.

Is NCT04162509 still recruiting?

NCT04162509 is currently completed. Last updated 20 December 2019.

Last reviewed 2019-12-20 · How we verify

NCT04162509: GARET2019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of a Gamified Augmented Reality Exposure-based Application in Subjects With Fear of Spiders

Completed NA Last updated 20 December 2019

What this trial tests

NA trial testing AR app in Fear of Spiders in 60 participants. Completed in 4 December 2019.

Timeline

7 October 2019

Primary endpoint
4 December 2019

4 December 2019

Quick facts

Lead sponsor	Prof. Dominique de Quervain, MD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	60
Start date	7 October 2019
Primary completion	4 December 2019
Estimated completion	4 December 2019
Sites	1 location across Switzerland

Drugs / interventions tested

AR app

Conditions studied

Fear of Spiders — all drugs for Fear of Spiders →

Sponsor

Prof. Dominique de Quervain, MD

Who can join

Adults 18 to 40, any sex, with Fear of Spiders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the efficacy of a gamified augmented reality exposure app in individual with fear of spiders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Prof. Dominique de Quervain, MD trials

Trials by the same sponsor.

NCT04516603 — Influence of Fampridine on Working Memory in Healthy Subjects · Phase 2 · withdrawn
NCT07191288 — Assessing the Acute Effects of Virtual Reality Interventions on Stress · NA · not yet recruiting
NCT07191275 — Study on the Effect of Transcranial Magnetic Stimulation on the Perception of Emotional Images · NA · recruiting
NCT06047899 — Influence of Luteolin for Two Weeks on Memory in Healthy Subjects · NA · completed
NCT05847933 — Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04162509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Dominique de Quervain, MD
Last refreshed: 20 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04162509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing